Goldman Sachs Group Inc vs McKesson Corporation — how do they compare? Goldman Sachs Group Inc trades at $1,118.59 (market cap $339.87B), while McKesson Corporation trades at $824.26 (market cap $93.23B). The key difference: Goldman Sachs Group Inc is far larger — about 3.6× McKesson Corporation's market cap, and Goldman Sachs Group Inc pays the higher dividend (1.56%). Which is the better fit depends on your goals.
| GS | MCK | |
|---|---|---|
Market Cap | $339.87B | $93.23B |
Volume | 2,592,735 | — |
Sector | Financials | Health |
52-Week High | $1.15K | $995.69 |
52-Week Low | $700.41 | $659.01 |
Dividend Yield | 1.56% | 0.41% |
Enterprise Value | — | $97.87B |
Signals from Pluang's Aura AI — not financial advice
Goldman Sachs (GS) trades at $1,140, up 9.0% over 24 hours, with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $20.98 versus $14.47, and revenue growth from $58.28B in 2025 to $60.4B projected for 2026. Recent news highlights Goldman's role in leading high-profile IPOs including Anthropic, signaling strong investment banking pipeline strength.
Outlook remains positive with analyst consensus price target of $1,140K and 40% buy ratings, though RSI levels suggest potential near-term overbought conditions. Key risks include volatile cash flow patterns and high leverage, while institutional sentiment supports continued growth from M&A activity and AI-driven market opportunities.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →